Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Carilex Medical, Inc. (7726:TWSE), powered by AI.
Carilex Medical, Inc. is currently trading at $32.40. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Carilex Medical, Inc. on Alpha Lenz.
View Carilex Medical, Inc.'s valuation metrics on Alpha Lenz.
“Carilex Medical, Inc.'s ROE is -9.3%. Explore profitability and growth together.”
Ask for details →Carilex Medical, Inc. is a medical device manufacturer headquartered in Taoyuan, Taiwan, specializing in wound care management solutions. The company’s primary focus is on the research, development, and production of innovative products that help prevent and treat pressure ulcers, such as therapeutic support surfaces, medical-grade air beds, specialized chair cushions, and negative pressure wound therapy devices. These products are widely used in settings ranging from acute and long-term care wards to home care environments, addressing the needs of patients who are bedridden or mobility-impaired. Established in 1985, Carilex Medical serves a global market, including Europe, the Americas, New Zealand, Australia, and Taiwan, and emphasizes technological innovation and quality assurance in its manufacturing processes. The company plays a significant role in the healthcare equipment sector by offering advanced solutions to healthcare facilities and caregivers aiming to improve patient outcomes in wound prevention and management.
“Carilex Medical, Inc.'s ROE is -9.3%. Explore profitability and growth together.”
Ask for details →Carilex Medical, Inc. (ticker: 7726) is a company listed on TWSE in the Healthcare sector (Medical Devices).
The current price is 32.4 with a P/E ratio of -x and P/B of -x.
ROE is -9.33% and operating margin is -12.63%. Annual revenue is $339M.